Novo Nordisk A/S: Once-Weekly Mim8 Is Well-Tolerated And Efficacious In Children Living With Haemophilia A With And Without Inhibitors
Phase 3 FRONTIER3 interim analysis data presented at EAHAD 2025 showed that 74.3% of children on once-weekly Mim8 prophylaxis experienced zero treated bleeds Bagsværd, Denmark, 7 February 2025 – Novo ...
ET Auto3h
Volvo Cars will not pay Northvolt for battery joint venture stake
Last week, Volvo Cars agreed with Northvolt to take over its stake in the venture, which included a planned Gothenburg ...